Paloma Partners’s AbbVie ABBV Stock Holding History

Paloma Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,400	Closed	-$217K	–	745
2023 Q4	$217K	Buy	+1,400	New	+$204K	0.01%	609
2023 Q3	–	Sell	-1,000	Closed	-$135K	–	703
2023 Q2	$135K	Sell	1,000 -26,000	-96%	-$3.81M	﹤0.01%	635
2023 Q1	$4.3M	Buy	27,000 +20,000	+286%	+$3.06M	0.15%	117
2022 Q4	$1.13M	Sell	7,000 -15,900	-69%	-$2.44M	0.05%	338
2022 Q3	$3.07M	Buy	+22,900	New	+$3.29M	0.14%	122
2020 Q1	–	Sell	-14,600	Closed	-$1.29M	–	1169
2019 Q4	$1.29M	Buy	+14,600	New	+$1.21M	0.02%	824
2019 Q3	–	Sell	-22,800	Closed	-$1.66M	–	1898
2019 Q2	$1.66M	Sell	22,800 -50,400	-69%	-$3.96M	0.03%	490
2019 Q1	$5.9M	Buy	+73,200	New	+$5.99M	0.14%	136
2018 Q4	–	Sell	-50,100	Closed	-$4.74M	–	1219
2018 Q3	$4.74M	Buy	+50,100	New	+$4.75M	0.09%	196
2018 Q1	–	Sell	-3,600	Closed	-$348K	–	1885
2017 Q4	$348K	Sell	3,600 -52,400	-94%	-$4.94M	﹤0.01%	1478
2017 Q3	$4.98M	Hold	56,000	–	–	0.07%	283
2017 Q2	$4.06M	Sell	56,000 -481,100	-90%	-$32.3M	0.05%	393
2017 Q1	$35M	Sell	537,100 -45,500	-8%	-$2.86M	0.42%	26
2016 Q4	$36.5M	Buy	582,600 +566,600	+3,541%	+$34.6M	0.36%	28
2016 Q3	$1.01M	Buy	+16,000	New	+$1.04M	0.01%	1013
2016 Q1	–	Sell	-50,000	Closed	-$2.96M	–	1822
2015 Q4	$2.96M	Buy	+50,000	New	+$2.88M	0.08%	237

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Paloma Partners's ABBV Position: Q2 2025 in Review

Paloma Partners sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 5,775 shares — an estimated $1.21M sold.

Paloma Partners first reported a position in ABBV in Q3 2014 and held it in 35 quarters. The position peaked at $26M in Q2 2018. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

Paloma Partners reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
Paloma Partners sold 5,775 AbbVie shares in Q2 2025, an estimated $1.21M.
Paloma Partners first reported a position in AbbVie in Q3 2014 and held it in 35 quarters.
Paloma Partners's AbbVie position peaked at $26M in Q2 2018.
3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Paloma Partners's 13F filing for Q2 2025, filed 14 Aug 2025.